Pharma news

Reset all filters
Geography
Company
Refine search
Americas
Non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK) has brought another two patent challenges against Gilead over its hepatitis C medicine sofosbuvir.   8 December 2017
Pharma
An advocate general has said that regulatory authorities in “concerned” EU member states handling drug marketing authorisations are co-responsible for approved documents on data exclusivity.   7 December 2017
LSPN Europe 2017: IBM counsel on M&A, investments and artificial intelligence
Americas
An IBM counsel has discussed how companies can harness their IP and gave an overview of the impact of artificial intelligence on healthcare.   7 December 2017
Pharma
An end of procedure notice issued by a reference EU member state before the expiry of a basic patent may not be treated as equivalent to a marketing authorisation.   7 December 2017
Asia-Pacific
Basilea Pharmaceutica and Pfizer have reached a deal for a licence agreement for the antifungal medication Cresemba to cover China and 16 countries in the Asia-Pacific region.   7 December 2017
Pharma
The UK Supreme Court’s approach in Actavis v Eli Lilly brought the country closer to harmonisation with other European nations, but there’s still not a wholly consistent view on the doctrine of equivalents across Europe.   6 December 2017
Pharma
Panellists at the Life Sciences Patent Network Europe conference in London today discussed the challenges around a potential unitary supplementary protection certificate.   6 December 2017
Pharma
A lawyer speaking at the Life Sciences Patent Network Europe conference has said the US Patent Trial and Appeal Board (PTAB) has come under fire for not being politically independent.   6 December 2017
Americas
The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).   4 December 2017
Pharma
The World Health Organization (WHO) has released a study on the public health impact of counterfeit drugs, showing that tens of thousands of children die as a result of the problem every year.   30 November 2017